| UniProt ID | CO6_HUMAN | |
|---|---|---|
| UniProt AC | P13671 | |
| Protein Name | Complement component C6 | |
| Gene Name | C6 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 934 | |
| Subcellular Localization | Secreted. | |
| Protein Description | Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells.. | |
| Protein Sequence | MARRSVLYFILLNALINKGQACFCDHYAWTQWTSCSKTCNSGTQSRHRQIVVDKYYQENFCEQICSKQETRECNWQRCPINCLLGDFGPWSDCDPCIEKQSKVRSVLRPSQFGGQPCTAPLVAFQPCIPSKLCKIEEADCKNKFRCDSGRCIARKLECNGENDCGDNSDERDCGRTKAVCTRKYNPIPSVQLMGNGFHFLAGEPRGEVLDNSFTGGICKTVKSSRTSNPYRVPANLENVGFEVQTAEDDLKTDFYKDLTSLGHNENQQGSFSSQGGSSFSVPIFYSSKRSENINHNSAFKQAIQASHKKDSSFIRIHKVMKVLNFTTKAKDLHLSDVFLKALNHLPLEYNSALYSRIFDDFGTHYFTSGSLGGVYDLLYQFSSEELKNSGLTEEEAKHCVRIETKKRVLFAKKTKVEHRCTTNKLSEKHEGSFIQGAEKSISLIRGGRSEYGAALAWEKGSSGLEEKTFSEWLESVKENPAVIDFELAPIVDLVRNIPCAVTKRNNLRKALQEYAAKFDPCQCAPCPNNGRPTLSGTECLCVCQSGTYGENCEKQSPDYKSNAVDGQWGCWSSWSTCDATYKRSRTRECNNPAPQRGGKRCEGEKRQEEDCTFSIMENNGQPCINDDEEMKEVDLPEIEADSGCPQPVPPENGFIRNEKQLYLVGEDVEISCLTGFETVGYQYFRCLPDGTWRQGDVECQRTECIKPVVQEVLTITPFQRLYRIGESIELTCPKGFVVAGPSRYTCQGNSWTPPISNSLTCEKDTLTKLKGHCQLGQKQSGSECICMSPEEDCSHHSEDLCVFDTDSNDYFTSPACKFLAEKCLNNQQLHFLHIGSCQDGRQLEWGLERTRLSSNSTKKESCGYDTCYDWEKCSASTSKCVCLLPPQCFKGGNQLYCVKMGSSTSEKTLNICEVGTIRCANRKMEILHPGKCLA | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 29 | C-linked_Glycosylation | CFCDHYAWTQWTSCS CCCCCCEEECCEECC | 5.07 | 10551839 | |
| 29 | C-linked_Glycosylation | CFCDHYAWTQWTSCS CCCCCCEEECCEECC | 5.07 | 10551839 | |
| 32 | C-linked_Glycosylation | DHYAWTQWTSCSKTC CCCEEECCEECCCCC | 5.27 | 10551839 | |
| 32 | C-linked_Glycosylation | DHYAWTQWTSCSKTC CCCEEECCEECCCCC | 5.27 | 10551839 | |
| 38 | O-linked_Glycosylation | QWTSCSKTCNSGTQS CCEECCCCCCCCCCC | 10.71 | 22267737 | |
| 41 | Phosphorylation | SCSKTCNSGTQSRHR ECCCCCCCCCCCHHE | 45.42 | 18452278 | |
| 45 | Phosphorylation | TCNSGTQSRHRQIVV CCCCCCCCHHEEEEH | 29.86 | 18452278 | |
| 90 | C-linked_Glycosylation | LLGDFGPWSDCDPCI EECCCCCHHHCHHHH | 13.74 | 10551839 | |
| 90 | C-linked_Glycosylation | LLGDFGPWSDCDPCI EECCCCCHHHCHHHH | 13.74 | 10551839 | |
| 130 | Phosphorylation | AFQPCIPSKLCKIEE EECCCCCHHHCCCCC | 20.53 | 24719451 | |
| 162 | N-linked_Glycosylation | KLECNGENDCGDNSD EEEECCCCCCCCCCC | 51.80 | - | |
| 162 | N-linked_Glycosylation | KLECNGENDCGDNSD EEEECCCCCCCCCCC | 51.80 | 17623646 | |
| 278 | Phosphorylation | FSSQGGSSFSVPIFY CCCCCCCCCEEEEEE | 25.47 | 19007248 | |
| 311 | Phosphorylation | QASHKKDSSFIRIHK HHHHCCCCCHHHHHH | 35.71 | 25003641 | |
| 312 | Phosphorylation | ASHKKDSSFIRIHKV HHHCCCCCHHHHHHH | 34.52 | 24719451 | |
| 324 | N-linked_Glycosylation | HKVMKVLNFTTKAKD HHHHHHHCCCCCCHH | 34.89 | 17623646 | |
| 324 | N-linked_Glycosylation | HKVMKVLNFTTKAKD HHHHHHHCCCCCCHH | 34.89 | 17623646 | |
| 355 | Phosphorylation | EYNSALYSRIFDDFG CCCHHHHHHHCCCCC | 21.54 | 24719451 | |
| 392 | O-linked_Glycosylation | ELKNSGLTEEEAKHC HHHHCCCCHHHHHHH | 44.89 | 22267737 | |
| 561 | Phosphorylation | KQSPDYKSNAVDGQW CCCCCCCCCCCCCCC | 24.64 | - | |
| 568 | C-linked_Glycosylation | SNAVDGQWGCWSSWS CCCCCCCCCCCCCHH | 14.94 | 10551839 | |
| 568 | C-linked_Glycosylation | SNAVDGQWGCWSSWS CCCCCCCCCCCCCHH | 14.94 | 10551839 | |
| 571 | C-linked_Glycosylation | VDGQWGCWSSWSTCD CCCCCCCCCCHHCCC | 7.46 | 10551839 | |
| 571 | C-linked_Glycosylation | VDGQWGCWSSWSTCD CCCCCCCCCCHHCCC | 7.46 | 10551839 | |
| 574 | C-linked_Glycosylation | QWGCWSSWSTCDATY CCCCCCCHHCCCCCC | 7.67 | 10551839 | |
| 574 | C-linked_Glycosylation | QWGCWSSWSTCDATY CCCCCCCHHCCCCCC | 7.67 | 10551839 | |
| 727 | Phosphorylation | RLYRIGESIELTCPK HHHCCCCCEEEECCC | 19.02 | 24505115 | |
| 731 | Phosphorylation | IGESIELTCPKGFVV CCCCEEEECCCCEEE | 17.61 | 24505115 | |
| 742 | Phosphorylation | GFVVAGPSRYTCQGN CEEEECCCCEECCCC | 36.68 | - | |
| 767 | Phosphorylation | TCEKDTLTKLKGHCQ EECCCHHHHHCCCCC | 36.10 | - | |
| 855 | N-linked_Glycosylation | ERTRLSSNSTKKESC HHHCCCCCCCCCHHC | 50.77 | 16335952 | |
| 855 | N-linked_Glycosylation | ERTRLSSNSTKKESC HHHCCCCCCCCCHHC | 50.77 | 16335952 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of CO6_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of CO6_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of CO6_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| CO5_HUMAN | C5 | physical | 2808363 | |
| SART3_HUMAN | SART3 | physical | 21988832 | |
| D19L3_HUMAN | DPY19L3 | physical | 28514442 | |
| ACOT9_HUMAN | ACOT9 | physical | 28514442 | |
| B3GLT_HUMAN | B3GALTL | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 612446 | Complement component 6 deficiency (C6D) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| C-linked Glycosylation | |
| Reference | PubMed |
| "Structure of complement C6 suggests a mechanism for initiation andunidirectional, sequential assembly of membrane attack complex(MAC)."; Aleshin A.E., Schraufstatter I.U., Stec B., Bankston L.A.,Liddington R.C., DiScipio R.G.; J. Biol. Chem. 287:10210-10222(2012). Cited for: X-RAY CRYSTALLOGRAPHY (2.87 ANGSTROMS) OF 22-934, GLYCOSYLATION ATTRP-29; TRP-32; THR-38; ASN-324; THR-392; TRP-568 AND TRP-571,SUBUNIT, AND DISULFIDE BONDS. | |
| "The four terminal components of the complement system are C-mannosylated on multiple tryptophan residues."; Hofsteenge J., Blommers M., Hess D., Furmanek A., Miroshnichenko O.; J. Biol. Chem. 274:32786-32794(1999). Cited for: GLYCOSYLATION AT TRP-29; TRP-32; TRP-90; TRP-568; TRP-571 AND TRP-574. | |
| N-linked Glycosylation | |
| Reference | PubMed |
| "Structure of complement C6 suggests a mechanism for initiation andunidirectional, sequential assembly of membrane attack complex(MAC)."; Aleshin A.E., Schraufstatter I.U., Stec B., Bankston L.A.,Liddington R.C., DiScipio R.G.; J. Biol. Chem. 287:10210-10222(2012). Cited for: X-RAY CRYSTALLOGRAPHY (2.87 ANGSTROMS) OF 22-934, GLYCOSYLATION ATTRP-29; TRP-32; THR-38; ASN-324; THR-392; TRP-568 AND TRP-571,SUBUNIT, AND DISULFIDE BONDS. | |
| "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry."; Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.; J. Proteome Res. 4:2070-2080(2005). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-324 AND ASN-855, AND MASSSPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-278, AND MASSSPECTROMETRY. | |